试管婴儿技术，只选对的，不选贵的

Core Findings - A study led by Huang Hefeng, an academician from the Chinese Academy of Sciences, published in the British Medical Journal, indicates that for severe male infertility patients, the more expensive third-generation IVF technology does not show a higher live birth rate compared to the second-generation technology [1][2] - This conclusion provides critical evidence for international treatment guidelines and is expected to significantly reduce infertility treatment costs, benefiting more families [1] Group 1: Study Details - The research involved a multi-center randomized controlled trial conducted over several years at reproductive medicine centers including Zhejiang University, Fudan University, and Shanghai Jiao Tong University, with a total of 450 couples with severe male infertility [1] - Participants were divided into two groups: 225 couples received conventional second-generation IVF treatment, while 225 couples received second-generation IVF combined with third-generation technology [1] - Results showed no significant difference in live birth rates between the two groups for both the first embryo transfer and the cumulative live birth rate over one year [1] Group 2: Implications for Patients - Approximately 50 million individuals in China face infertility issues annually, with male factors accounting for 40% of these cases [2] - Many patients previously opted for the "higher-level" third-generation technology, which costs around 20,000 to 30,000 yuan per single test [2] - The study aims to help patients avoid unnecessary medical expenses, alleviate financial burdens, and correct misconceptions in the use of assisted reproductive technologies [2] - The principle emphasized is to choose the right technology rather than the more expensive one, ensuring the health and safety of offspring [2]